Women of reproductive age must be on adequate birth control, either oral contraceptives or using condoms or other barrier methods with spermicidal agents.
Subjects may be undergoing psychotherapy, but must maintain current psychotherapy status. Must not start therapy if not already in therapy. If in therapy, must have received at least 6 sessions prior to entering the study.
Subjects may continue taking herbals or supplements during the study, but they may not start any new herbals or supplements during the study.
You may not be if
2 or more failed trials of antidepressants (adequate dose and duration, and documented).
Substance dependence in the past 6 months.
Current substance use or abuse (MJ, benzodiazepines, narcotics). If BZD use, patient must be tapered off and wait 1 month before being included in the trial.
Psychosis.
Bipolar Affective Disorder Type I, II or NOS.
Pregnancy (current or planned).
Unstable medical illness (pt has to be stable for at least 3 months, and may be excluded per investigator discretion).
Dementia.
Mental retardation.
Traumatic Brain Injury.
History of Stroke.
History of seizure disorder.
Electroconvulsive therapy within past 6 months.
If, at the investigator's discretion, it is suspected that the subject will likely not comply with the study protocol.
Imminent risk for suicide.
Clareo Health | Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response
